In the matter of musculoskeletal issues, researchers point to an increased reliance on opioids for pain management, which increases overall costs but offers little overall improvement in quality of life.
As the high cost of health care remains a top financial stressor for many Americans, consumers must struggle with the question of whether a particular medical service is worth the price. IT's becoming an even more pressing question as new innovations come to market, including million-dollar cancer drugs and costly gene therapies.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Emily Payne
Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.
